Compare Stocks

GP Strategies Corp. provides training, e-Learning solutions, management consulting and engineering services. It operates through the following Geographic Segments: North America, EMEA and Emerging Markets (Latin America and Asia Pacific countries). It provides Workforce Transformation Services into three primary solution sets: Organizational Performance Solutions (OPS), Technical Performance Solutions (TPS) and Automotive Performance Solutions (APS). The company was founded in 1959 and is headquartered in Columbia, MD.

Guggenheim Shipping ETF (the Fund) seeks investment results that correspond generally to the performance of Delta Global Shipping Index (the Index). The Index is designed to measure the performance of companies listed on global developed market exchanges and consists of companies within the maritime shipping industry. The index provider, Delta Global Indices, LLC, defines the shipping industry to include companies within the business segments of the maritime shipping industry, such as companies deriving revenue from the seaborne transport of dry bulk goods and the leasing and/or operating of tanker ships, container ships, specialty chemical ships and ships that transport liquid natural gas (LNG) or dry bulk goods. The Fund will invest at least 90% of its total assets in common stock, American depositary receipts (ADRs), global depositary receipts (GDRs) and master limited partnerships (MLPs). The Fund's investment adviser is Guggenheim Funds Investment Advisors, LLC.

ShangPharma Corporation (ShangPharma) is a China-based holding company. The Company is a pharmaceutical and biotechnology research and development (R&D) outsourcing company. It provides a range of high-quality, integrated services across the drug discovery and development process to international and Chinese pharmaceutical and biotechnology companies. Its services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. It has a diversified and loyal global customer base. In March 2013, the Company completed the merger contemplated by the previously announced Agreement and Plan of Merger (the Merger Agreement), by and among the Company, ShangPharma Holdings Limited (Holdings), ShangPharma Parent Limited (Parent) and ShangPharma Merger Sub Limited (Merger Sub). As a result of the merger, the Company became a wholly owned subsidiary of Parent.